why choose us

Course: “Nanotraps” Designed to Capture and Clear SARS-CoV-2

CME Credits: 1.00

Released: 2021-06-08

An interdisciplinary team led by University of Chicago researchers is designing biodegradable nanomedicines to capture and clear the novel coronavirus. The “” are dotted with angiotensin-converting enzyme 2 (ACE2) receptors or SARS-CoV-2 neutralizing antibodies that bind the virus and prevent it from infecting cells.
The researchers tested the virus-trapping particles’ safety and effectiveness in several experiments. When a SARS-CoV-2 pseudovirus and the nanotraps engineered with antibodies were injected into a healthy human lung in an ex vivo lung perfusion system, tissue sampling confirmed that the particles blocked infection. Both types of nanotraps also blocked human cell line infection with a SARS-CoV-2 pseudovirus.


Educational Objective
To identify the key insights or developments described in this article


View Full Course